Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M700374-JLR200 on April 27, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M700374-JLR200v1
49/8/1682    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masson, D.
Right arrow Articles by Assem, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masson, D.
Right arrow Articles by Assem, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 49, 1682-1691, August 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice

David Masson*,{dagger}, Mohamed Qatanani§, Anne Laure Sberna*,{dagger}, Rui Xiao§, Jean Paul Pais de Barros*,{dagger}, Jacques Grober*,{dagger}, Valerie Deckert*,{dagger}, Anne Athias*,{dagger}, Philippe Gambert*,{dagger}, Laurent Lagrost*,{dagger}, David D. Moore§ and Mahfoud Assem1,**

* Institut National de la Santé et de la Recherche Médicale U866, Faculté de Médecine, BP 87900, 21079 Dijon Cedex, France
{dagger} Institut Federatif de Recherche 100, Faculté de Médecine, BP 87900, 21079 Dijon Cedex, France
§ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030
** Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, IA 52242

This work was supported by the University of Iowa College of Pharmacy start-up funds, the Conseil Régional de Bourgogne, the Fondation de France, the Université de Bourgogne, and the Institut National de la Santé et de la Recherche Médicale.

Published, JLR Papers in Press, April 27, 2008.

1To whom correspondence should be addressed. e-mail: mahfoud-assem{at}uiowa.edu

The nuclear hormone receptor constitutive androstane receptor (CAR, NR1I3) regulates detoxification of xenobiotics and endogenous molecules, and has been shown to be involved in the metabolism of hepatic bile acids and cholesterol. The goal of this study was to address potential effects of CAR on the metabolism of HDL particles, key components in the reverse transport of cholesterol to the liver. Wild-type (WT) mice, transgenic mice expressing human apolipoprotein A-I (HuAITg), and CAR-deficient (CAR–/–) mice were treated with the specific CAR agonist 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP). CAR activation decreased HDL cholesterol and plasma apolipoprotein A-I (apoA-I) levels in both WT and HuAITg mice, but not CAR–/– mice. Both mouse apoA-I and human apoA-I were decreased by more than 40% after TCPOBOP treatment, and kinetic studies revealed that the production rate of HDL is reduced in TCPOBOP-treated WT mice. In transient transfections, TCPOBOP-activated CAR decreased the activity of the human apoA-I promoter. Although loss of CAR function did not alter HDL levels in normal chow-fed mice, HDL cholesterol, apoA-I concentration, and apoA-I mRNA levels were increased in CAR–/– mice relative to WT mice when both were fed a high-fat diet. We conclude that CAR activation in mice induces a pronounced decrease in circulating levels of plasma HDL, at least in part through downregulation of apoA-I gene expression.

Supplementary key words apolipoprotein A-I • bile acids • cholesterol • 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene

Abbreviations: apoA-I, apolipoprotein A-I; CAR, constitutive androstane receptor; CAR–/– mice, CAR-deficient mice; CE, cholesteryl ester; FCR, fractional catabolic rate; FPLC, fast-protein liquid chromatography; FXR, farnesoid X receptor; HuAITg mice, transgenic mice expressing human apolipoprotein A-I; LXR, liver X receptor; PPAR{alpha} peroxisome proliferator-activated receptor {alpha}; PXR, pregnane X receptor; TCPOBOP, 1,4-bis-[2-(3,5-dichloropyridyloxy)] benzene; WT, wild type


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. G. DeKeyser, M. C. Stagliano, S. S. Auerbach, K. S. Prabhu, A. D. Jones, and C. J. Omiecinski
Di(2-ethylhexyl) phthalate Is a Highly Potent Agonist for the Human Constitutive Androstane Receptor Splice Variant CAR2
Mol. Pharmacol., May 1, 2009; 75(5): 1005 - 1013.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. M. Maglich, D. C. Lobe, and J. T. Moore
The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress
J. Lipid Res., March 1, 2009; 50(3): 439 - 445.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement